Drug resistance in tuberculosis

Infectious Disease Clinics of North America

Volumn 11, Issue 4, 1997, Pages 905-928

  Parsons, L M ^a   Driscoll, J R ^a   Taber, H W ^a   Salfinger, M ^a  

^a WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

BACTERIAL GENE; DRUG CHOICE; GENE MUTATION; HUMAN; LABORATORY DIAGNOSIS; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATIENT COMPLIANCE; REVIEW; STRAIN DIFFERENCE; TUBERCULOSIS;

EID: 0031467173     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70397-4     Document Type: Article

References (83)

1. A. Banerjee E. Dubnau A. Quemard inhA , a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis Science 263 1994 172
2. C.E. Barry K. Mdluli Drug sensitivity and environmental adaptation of mycobacterial cell wall components Trends Microbiol 4 1996 275
3. J.S. Blanchard Molecular mechanisms of drug resistance in Mycobacterium tuberculosis Annu Rev Biochem 65 1996 215
4. T. Bodmer G. Zürcher P. Imbdoen Mutation position and type of substitution in the β-subunit of the RNA polymerase influence in vitro activity of rifamycins in rifampin-resistant Mycobacterium tuberculosis J Antimicrobiol Chemother 35 1995 345
5. E.C. Böttger Resistance to drugs targeting protein synthesis in mycobacteria Trends Microbiol 2 1994 416
6. M.A. Brow M.C. Oldenburg V. Lyamichev Differentiation of bacterial 16S rRNA genes and intergenic regions and Mycobacterium tuberculosis katG genes by structure-specific endonuclease cleavage J Clin Microbiol 34 1996 3129
7. K. Brudney J. Dobkin Resurgent tuberculosis in New York City—Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs Am Rev Respir Dis 144 1991 745
8. L.E. Bryan Bacterial Resistance and Susceptibility to Chemotherapeutic Agents 1982 Cambridge University Press Cambridge, England
9. G. Canetti Present aspects of bacterial resistance in tuberculosis Am Rev Respir Dis 92 1965 687
10. Centers for Disease Control Tuberculosis—United States, first 39 weeks MMWR Morb Mort Wkly Rep 34 1985 625
11. Centers for Disease Control Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons—Florida and New York, 1988–1991 MMWR Morb Mort Wkly Rep 40 1991 585
12. M.R. Chassin Health challenges for the 1990s NY State J Med 93 1993 1
13. C.P. Chaulk K. Moore-Rice R. Rizzo Eleven years of community-based directly observed therapy for tuberculosis JAMA 274 1995 945
14. D.L. Cohn F. Bustreo M.C. Raviglione Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project Clin Infect Dis 24 Suppl 1 1997 S121
15. S.T. Cole Rifamycin resistance in mycobacteria Res Microbiol 147 1996 48
16. S.T. Cole Mycobacterium tuberculosis : drug-resistance mechanisms Trends Microbiol 2 1994 411
17. M.J. Colston E.O. Davis Homologous recombination, DNA repair, and mycobacterial recA genes Bloom B.R. Tuberculosis: Pathogenesis, Protection and Control 1994 American Society for Microbiology Washington, DC 217 226
18. G.W. Comstock S.F. Woolpert Preventive therapy Kubica G.P. Wayne L.G. The Mycobacteria. A Sourcebook 1984 Marcel Dekker New York 1074 1075
19. J. Crofton D.A. Mitchison Streptomycin resistance in pulmonary tuberculosis Br Med J 2 1948 1009
20. E.R. Dabbs K. Yazawa Y. Mikami Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation Antimicrob Agents Chemother 39 1995 1007
21. L. Deng K. Mikusova K.G. Robuck Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope Antimicrob Agents Chemother 39 1995 694
22. V. Deretic W. Philipp S. Dhandayuthapani Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity for isoniazid Mol Microbiol 17 1995 889
23. A. Dessen A. Quemard J.S. Blanchard Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis Science 267 1995 1638
24. S.W. Dooley W.R. Jarvis W.J. Martone Multidrug-resistant tuberculosis [editorial] Ann Intern Med 117 1992 257
25. M.R.W. Ehlers The wolf at the door: some thoughts on the biochemistry of the tubercle bacillus S Afr Med J 83 1993 900
26. W. El-Sadr F. Medard V. Barthaud Directly observed therapy for tuberculosis: The Harlem Hospital experience, 1993 Am J Publ Hlth 86 1996 1146
27. J.O. Falkingham J.T. Crawford Plasmids Bloom B.R. Tuberculosis: Pathogenesis, Protection and Control 1994 American Society for Microbiology Washington, DC 185 198
28. M. Goble M.D. Iseman L.A. Madsen Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin N Engl J Med 328 1993 527
29. E.P. Gormley J. Davies Transfer of plasmid RSF1010 by conjugation from Escherichia coli to Streptomyces lividans and Mycobacterium smegmatis J Bacteriol 173 1991 6705
30. G. Hatfull The molecular genetics of Mycobacterium tuberculosis Current Topics Microbiol Immunol 215 1996 29
31. B. Heym P.M. Alzari N. Honorè Missense mutations in the catalase-peroxidase gene, katG , are associated with isoniazid resistance in Mycobacterium tuberculosis Mol Microbiol 15 1995 235
32. B. Heym W. Philipp S.T. Cole Mechanisms of drug resistance in Mycobacterium tuberculosis Current Topics Microbiol Immunol 215 1996 49
33. J. Hui N. Gordon R. Kajoika Permeability barrier to rifampin in mycobacteria Antimicrob Agents Chemother 11 1977 773
34. C.B. Inderlied K.A. Nash Antimycobacterial agents: in vitro susceptibility testing, spectra of activity, mechanisms of action and resistance, and assays for activity in biologic fluids Lorian V. Antibiotics in Laboratory Medicine ed 4 1996 Williams & Wilkins Baltimore 127
35. P.S. Jackett V.R. Aber D.A. Mitchison The relationship between nicotinamide-adenine-dinucleotide concentration and antibacterial activity of isoniazid in Mycobacterium tuberculosis Am Rev Resp Dis 115 1977 601
36. W.R. Jacobs R. Udani R. Barletta Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages Science 260 1993 819
37. V. Lorian M. Finland In vitro effect of rifampin on mycobacteria Applied Microbiol 17 1969 202
38. M. Lutfey P. Della-Latta V. Kapur Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS Am J Respir Crit Care Med 153 1996 837
39. A. Mahmoudi M.D. Iseman Pitfalls in the care of patients with tuberculosis: Common errors and their association with the acquisition of drug resistance JAMA 270 1993 65
40. R.A. McAdam C. Guilhot B. Gicquel Transposition in mycobacteria Bloom B. Tuberculosis: Pathogenesis, Protection and Control 1994 American Society for Microbiology Washington, DC 199 216
41. J. McFadden Recombination in mycobacteria Mol Microbiol 21 1996 205
42. M.R. McNeil P.J. Brennan Structure, function and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance; some thoughts and possibilities arising from recent structural information Res Microbiol 142 1991 451
43. L.P. Miller J.T. Crawford T.M. Shinnick The rpoB gene of Mycobacterium tuberculosis Antimicrob Agents Chemother 38 1994 805
44. D.E. Minnikin Chemical principles in the organization of lipid components in the mycobacterial cell envelope Res Microbiol 142 1991 423
45. R.D. Moore C.P. Chaulk R. Griffiths Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis Am J Respir Crit Care Med 154 1996 1013
46. J. Nair D.A. Rouse Bai G.-H. The rpsL gene and streptomycin resistance in single and multiple drug-resistant strains of Mycobacterium tuberculosis Mol Microbiol 10 1993 512
47. K.A. Nash C.B. Inderlied Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex Antimicrob Agents Chemother 40 1996 1748
48. H. Nikaido Prevention of drug access to bacterial targets: permeability barriers and active efflux Science 264 1994 382
49. H. Nikaido V. Jarlier Permeability of the mycobacterial cell wall Res Microbiol 142 1991 437
50. A.T. Nitta P.T. Davidson de Koning M.L. Misdiagnosis of multidrug-resistant tuberculosis possibly due to laboratory-related errors JAMA 276 1996 1980
51. C.M. Nolan D.L. Williams M.D. Cave Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis Am J Respir Crit Care Med 152 1995 1067
52. H. Ohno H. Koga S. Kohno Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan Antimicrob Agents Chemother 40 1996 1053
53. Y. Pang B.A. Brown V.A. Steingrube Tetracycline resistance determinants in Mycobacterium and Streptomyces species Antimicrob Agents Chemother 38 1994 1408
54. M. Picardeau V. Vincent Characterization of large linear plasmids in mycobacteria J Bacteriol 179 1997 2753
55. Press Conference honoring World TB Day at Harlem Hospital Center, New York, March 24, 1997.
56. Pretorius G.S. Van Helden P.D. F. Sirgel Mutations in katG gene sequences in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis are rare Antimicrob Agents Chemother 39 1995 2276
57. M. Pyle Relative number of resistant tubercle bacilli in sputa of patients before and during treatment with streptomycin Proc Mayo Clin 22 1947 465
58. N. Rastogi W.W. Barrow Cell envelope constituents and the multifaceted nature of Mycobacterium avium pathogenicity and drug resistance Res Microbiol 145 1994 243
59. N. Rastogi H.L. David Mode of action of antituberculosis drugs and mechanisms of drug resistance in Mycobacterium tuberculosis Res Microbiol 144 1993 133
60. D.A. Rouse Z. Li Bai G.-H. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis Antimicrob Agents Chemother 39 1995 2472
61. M. Salfinger M.J. Fitzgerald H.W. Taber How rapidly do New York State tuberculosis laboratories report drug susceptibility testing results to physicians? [abstract]. International Conference May 11–15, 1996 American Thoracic Society New Orleans, LA
62. M. Salfinger G.E. Pfyffer The new diagnostic mycobacteriology laboratory Eur J Clin Microbiol Infect Dis 11 1994 961
63. P. Sander A. Meier E.C. Böttger Mechanisms of drug resistance in mycobacteria: macrolides and aminoglycosides Res Microbiol 147 1996 59
64. K.A. Sepkowitz E.E. Telzak S. Recalde New York City Area Tuberculosis Working Group: Trends in the susceptibility of tuberculosis in New York City, 1987–1991 Clin Infect Dis 18 1994 755
65. P. Small Tuberculosis research: balancing the portfolio JAMA 276 1996 1512
66. P.M. Small N.B. McClenny S.P. Singh Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures J Clin Microbiol 31 1993 1677
67. S. Sreevatsan K.E. Stockbauer X. Pan Ethambutol resistance in Mycobacterium tuberculosis: Critical role of embB mutations Antimicrob Agents Chemother 41 1997 1677
68. K. Takayama J.O. Kilburn Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis Antimicrob Agents Chemother 33 1989 1493
69. A. Telenti N. Honoré C. Bernasconi Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level J Clin Microbiol 35 1997 719
70. A. Telenti P. Imboden F. Marchesi Detection of rifampin-resistant mutations in Mycobacterium tuberculosis Lancet 341 1993 647
71. S. Valway S. Dooley R. Ikeda False positive diagnosis of multidrug-resistant tuberculosis due to laboratory contamination [abstract] Tubercle Lung Dis 75 Suppl 1 1994 42
72. L.G. Wayne Dormancy of Mycobacterium tuberculosis and latency of disease Eur J Clin Microbiol Infect Dis 13 1994 908
73. L.G. Wayne L.G. Hayes An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence Infect Immun 64 1996 2062
74. L.G. Wayne H.A. Sramek Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis Antimicrob Agents Chemother 38 1994 2054
75. S.E. Weis P.C. Slocum F.X. Blais The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis N Engl J Med 330 1994 1179
76. D.L. Williams C. Waguespack K. Eisenach Characterization of rifampin resistance in pathogenic mycobacteria Antimicrob Agents Chemother 38 1994 2380
77. T.M. Wilson D.M. Collins aphC , a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex Mol Microbiol 19 1996 1025
78. Winslow C.-E.A. The Life of Hermann M. Biggs—Physician and Statesman of the Public Health 1929 Lea & Febiger Philadelphia
79. R. Wurtz P. Demarais W. Trainor Specimen contamination in mycobacteriology laboratory detection by pseudo-outbreak of multidrug-resistant tuberculosis: Analysis by routine epidemiology and confirmation by molecular technique J Clin Microbiol 34 1996 1017
80. D. Young TB research: entering the post-genomic era Modern Medicine Today January: 6, 1997
81. D.B. Young K. Duncan Prospects for new interventions in the treatment and prevention of mycobacterial disease Annu Rev Microbiol 49 1995 641
82. Y. Zhang S. Dhandayuthapani V. Deretic Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid Proc Natl Acad Sci USA 93 1996 13212
83. Y. Zhang D.B. Young Molecular mechanisms of isoniazid: a drug at the front line of tuberculosis control Trends Microbiol 1 1993 109